SpaceX Stock: Buy, Sell, or Hold?

SpaceX (via Space Exploration Technologies, SPCX) is trading around $143 after a 50% IPO pop to a $225 all-time high, and the article argues it’s not a buy due to ballooning spend. Capex in 1H 2026 is cited at $28.5B, up 308% vs 1H 2025, largely tied to AI data centers (86% of Q2 capex), while Q2 sales were only $7.8B—implying capex runs at over 2x revenue. The stock’s valuation is highlighted as extreme (P/S ~65 vs tech sector ~7), leading to a cautious hold stance for existing investors unless position sizes are small and investors can tolerate volatility.

Analysis

The market is likely underestimating how much this setup behaves like a financing story, not an operating story. When capex is running materially ahead of revenue, the equity’s value becomes hostage to either a step-change in monetization or a future capital raise; that usually compresses multiples before it improves fundamentals. Near term, the stock can stay disconnected from fundamentals, but over the next 1-3 quarters the burden shifts to proof of utilization, customer contracts, and whether spending is actually translating into durable gross profit.

Second-order, the AI-data-center angle cuts both ways. If the buildout is real, suppliers of accelerators, networking, and power infrastructure can still see order flow, but the market should be wary of a vertically integrated provider trying to compete against its own prospective customers. That typically slows adoption, lengthens payback periods, and raises the odds that the asset base earns subpar returns even if revenue grows.

The contrarian view is that consensus may be too focused on current P/S and not enough on strategic optionality: a scarce compute footprint can be re-rated if it lands large anchor tenants or internal AI products with distribution leverage. The thesis is falsified by either a capex slowdown without revenue acceleration, or by any disclosure that utilization/contracted backlog remains thin after another reporting cycle. In that case, the premium should trade more like a speculative infrastructure asset than a platform compounder.

Key Decisions for Investors

• Short SPCX on any failed rebound toward the post-IPO range; use a 1-3 month horizon and target a 15-25% downside if the next disclosure does not show clear monetization traction. Invalidated if management shows contracted backlog/utilization inflecting faster than capex.
• If borrow/liquidity are workable, pair long NVDA / short SPCX for a 1-2 quarter trade: keep exposure to AI capex beneficiaries while expressing the view that the spender gets punished for poor capital efficiency. Cover if SPCX starts showing revenue growth > capex growth for two consecutive quarters.
• Favor capital-light AI exposure over SPCX: rotate new money into SMH or XLK rather than speculative compute-buildout stories. This is a relative-value allocation, not a timing bet; the risk is an abrupt sentiment squeeze if the company announces meaningful third-party demand.
• Set an alert on any financing event, debt issuance, or equity sale tied to the AI buildout; that would be the cleanest catalyst for a valuation reset and likely the best entry point for shorts.